TRP channels in COVID-19 disease: Potential targets for prevention and treatment
Abstract Coronavirus disease 2019 [COVID-19] is a global health threat caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV2] that…
COVID - 19
Representations of Psychoactive Drugs’ Use in Mass Culture and Their Impact on Audiences
Abstract Drug use has been increasing worldwide over recent decades. Apart from the determinants of drug initiation established in numerous…
Overview of sleep management during COVID-19
Abstract The sleep of millions has suffered during the global COVID-19 pandemic. Prevalence rates of 20–45% are reported globally for…
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
Abstract Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to…
Changes in drug use in European cities during early COVID-19 lockdowns – A snapshot from wastewater analysis
Abstract The COVID-19 outbreak has forced countries to introduce severe restrictive measures to contain its spread. In particular, physical distancing…
Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 Infection
Abstract Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (Covid-19), has been a serious threat…
A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2
Abstract Graphic abstract: Article type: Review Article Keywords: Phytocannabinoid, Δ, Cannabidiol, SARS-CoV2, Covid-19, Dronabinol, Epidiolex Authors: Neda Tadayon, Ali Ramazani…
A model for occupational stress amongst paediatric and adult critical care staff during COVID-19 pandemic
Abstract Purpose: The coronavirus 2019 pandemic has placed all intensive care unit (ICU) staff at increased risk of psychological distress.…
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to coronavirus disease 2019 (COVID-19) which, in turn, may…
Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review
Abstract Background: The COVID-19 pandemic is creating severe issues for healthcare and broad social structures, exposing societal vulnerabilities. Among the…